Barr Pharmaceuticals (NYSE: BRL) announced the U.S. Patent and Trademark Office (PTO) issued U.S. Patent No. 7,320,969 for the Company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE